Molecular screening for diseases frequent in Ashkenazi Jews: lessons learned from more than 100,000 tests performed in a commercial laboratory.
OBJECTIVE
To determine the frequency of carriers of Ashkenazi Jewish (AJ) genetic diseases in the US population and compare these numbers with previously published frequencies reported in smaller more isolated cohorts.


METHODS
A database containing more than 100,000 genotyping assays was queried. Assays for 10 separate AJ genetic diseases where comparisons were made with published data.


RESULTS
As expected, we observed lower carrier frequencies in a general, US population than those reported in literature. In 2427 patients tested for a panel of 8 AJ diseases, 20 (1:121) were carriers of two diseases and 331 (1:7) were carriers of a single disease. Fifty-three of 7184 (1:306) individuals tested for Gaucher disease had 2 Gaucher Disease mutations indicating a potentially affected phenotype.


CONCLUSIONS
As the number of AJ diseases increases, progressively more individuals will be identified as carriers of at least one disease.
Strom
Charles M
CM
Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA 92690, USA.
Crossley
Beryl
B
Redman
Joy B
JB
Quan
Franklin
F
Buller
Arlene
A
McGinniss
Matthew J
MJ
Sun
Weimin
W
D005787:Gene Frequency; D006580:Genetic Carrier Screening; D030342:Genetic Diseases, Inborn / Q000235:genetics*; D005820:Genetic Testing; D005828:Genetics, Population; D006801:Humans; D007585:Jews; D007753:Laboratories; D009154:Mutation; D019683:Penetrance; D014481:United States